M-protein de novo sequencing and tracking
downstream-application
M-protein de novo sequencing and tracking: downstream-application. De novo sequencing of the patient-specific M-protein followed by a targeted MS/MS assay tracks multiple myeloma in serum far more sensitively than SPEP or IFE.
De novo sequencing of the patient-specific M-protein followed by a targeted MS/MS assay tracks multiple myeloma in serum far more sensitively than SPEP or IFE.
| Kind | downstream-application |
| Deep learning | no |
| Acquisition | DDA |
| Application area | Antibodyomics |
Paper describing it
- Mass Spectrometry Provides a Highly Sensitive Noninvasive Means of Sequencing and Tracking M-Protein in the Blood of Multiple Myeloma Patients (2021, Journal of Proteome Research, peer-reviewed)